16 September 1986
INTERIM COMMERCIAL ITEM DESCRIPTION
AMOXICILLIN AND POTASSIUM CLAVULANATE FOR ORAL SUSPENSION
The General Services Administration has authorized the use of this Interim Commercial Item Description which was developed by the Defense Personnel Support Center, Directorate of Medical Material, DPSC-RST, 2800 South 20th Street, Philadelphia, PA 19101, based upon currently available technical information.
Shall be palatable Amoxicillin and Potassium Clavulanate for Oral Suspension.
For Strength 1, shall be supplied as a dry mixture equivalent to 3.75g. Amoxicillin and 0.9375g Clavulanic Acid (as the potassium salt). When reconstituted to 150 ml, each 5 ml shall contain the equivalent of 125 mg of Amoxicillin and 31.25 mg of Clavulanic Acid, within the applicable assay limits.
For Strength 2, shall be supplied as a dry mixture equivalent to 7.5g. Amoxicillin and 1.875g Clavulanic Acid (as the potassium salt). When reconstituted to 150 ml, each 5 ml shall contain the equivalent of 125 mg of Amoxicillin and 62.5 mg of Clavulanic Acid, within the applicable assay limits.
The finished suspension shall be palatable and pleasant to the taste with no unpleasant after-taste. Not later than the time specified for opening of bids or receipt of proposals, the offeror shall submit to the contracting officer six units of the finished suspension representative of the product which the offeror proposes to furnish. A portion of the samples will be subjected to panel testing for a determination of palatability. The remaining samples will be used by the cognizant Government inspection and quality assurance activities for determining compliance of supplies furnished hereunder with the palatability requirement. Approval as to
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business